Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: Case report [4]

AIDS

Volumn 21, Issue 11, 2007, Pages 1495-1496

  Celesia, Benedetto M ^a   Onorante, Anna ^a   Nunnari, Giuseppe ^a   Mughini, Maria T ^a   Mavilla, Sergio ^a   Massimino, Santa D ^b   Russo, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b ARNAS Garibaldi Nesima   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; CHLOROQUINE; ENFUVIRTIDE; LAMIVUDINE; LOPINAVIR; RITONAVIR; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE;

ADULT; BLISTER; CASE REPORT; CELLULITIS; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KAPOSI SARCOMA; LETTER; MONOTHERAPY; PAIN; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RASH; SKIN DEFECT; SKIN PRURITUS; THRUSH; UNSPECIFIED SIDE EFFECT;

ADENINE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LAMIVUDINE; MIDDLE AGED; PHOSPHONIC ACIDS; PORPHYRIA CUTANEA TARDA; PYRIDINES; PYRONES; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR;

EID: 34250896263     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328216f379     Document Type: Letter

References (7)

1. Melito VA, Parera A, Estela V, et al. Porphyria cutanea tarda manifestation in patients infected with human immunodeficiency virus. Acta Bioquím Clín Latinoam 2006; 40:29-34.
2. McAlister F, McClean K, Hamilton PG, Houston S. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? Clin Infect Dis 1995; 20:348-351.
3. Lacour JPH, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128:121-123.
4. Fox PA, Boag FC, Hawkins DA, Francis N. Acute porphyria following commencement of indinavir. AIDS 1999; 13:622-623.
5. Roca B, Lapuebla C, Roig B. Porphyria cutanea tarda induced by nelfinavir. Antiviral Ther 2001; 6 (Suppl. 4):71; Abstract no. 107.
6. Almehmi A, Deliri H, Szego GC, Teague AC, Pfister AK, Martin SA. Porphyria cutanea tarda in a patient with HIV-infection. WV Med J 2005; 101:19-21.
7. Hoen B, Towner W, Opravil M, Soriano V, Notter T, Cairms V, et al. The Aptivus Compassionate Use Program (CUP): safety and efficacy data from 3920 patients in the clinic. In: VIIIth International Conference on Drug Therapy in HIV Infection. Glasgow, UK, 12-16 November 2006. Abstract no. P162.